Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23728151 | 1.00 | MEN1 (0.49) | MEN1KMT2ATDP1L3MBTL1GMNN | |
| SCHEMBL10337271 | 0.98 | L3MBTL1 (0.50) | MEN1KMT2ATDP1L3MBTL1GMNN | |
| SCHEMBL692004 | 0.98 | L3MBTL1 (0.50) | MEN1KMT2ATDP1L3MBTL1GMNN | |
| SCHEMBL692068 | 0.98 | L3MBTL1 (0.50) | MEN1KMT2ATDP1L3MBTL1GMNN | |
| SCHEMBL10337272 | 0.98 | L3MBTL1 (0.50) | MEN1KMT2ATDP1L3MBTL1GMNN | |
| SCHEMBL30636021 | 0.98 | L3MBTL1 (0.50) | MEN1KMT2ATDP1L3MBTL1GMNN | |
| SCHEMBL692069 | 0.98 | L3MBTL1 (0.50) | MEN1KMT2ATDP1L3MBTL1GMNN | |
| SCHEMBL13090346 | 0.98 | L3MBTL1 (0.50) | MEN1KMT2ATDP1L3MBTL1GMNN | |
| SCHEMBL691996 | 0.97 | L3MBTL1 (0.49) | MEN1KMT2ATDP1L3MBTL1GMNN | |
| SCHEMBL691997 | 0.97 | L3MBTL1 (0.49) | MEN1KMT2ATDP1L3MBTL1GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115515614-A | Compositions comprising extracts of alpinia and other plants for improving joint health and treating arthritis | 尤尼根公司 | 2022-12-23 | — | — | CN | disclosed |
| EP-4100034-A1 | COMPOSITIONS COMPRISING EXTRACTS OF APLINIA AND OTHER PLANTS FOR IMPROVING JOINT HEALTH AND TREATING ARTHRITIS | Unigen, Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| US-20220000964-A1 | Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis | UNIGEN, INC. (US) | 2022-01-06 | — | — | US | disclosed |
| WO-2021159042-A1 | COMPOSITIONS COMPRISING EXTRACTS OF APLINIA AND OTHER PLANTS FOR IMPROVING JOINT HEALTH AND TREATING ARTHRITIS | UNIGEN, INC. (US) | 2021-08-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220000964-A1 | Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis | COL2A1, COL1A1, CKAP4 | MEN1 2515/4885KMT2A 1517/4885TDP1 3099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.